patent/IL-186355-A

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate	2007-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2016-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	IL-186355-A
titleOfInvention	Asnapine malt crystalline show, a method for making it, pharmacological preparations containing it, its uses for preparing pharmaceutical formulations for the treatment of mental disorders such as schizophrenia or bipolar disorder and its microcrystals
priorityDate	2005-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6917875 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449104644

Total number of triples: 16.